LLY vs. AUGO

Last updated Jun 13, 2026

LLY (Eli Lilly and Company) and AUGO (Aura Minerals Inc. Common Shares) are both stocks. LLY operates in Drug Manufacturers - General (Healthcare), while AUGO operates in Gold (Basic Materials). At a 0.04 correlation, their price movements are largely independent.

Performance

LLY vs. AUGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eli Lilly and Company (LLY) and Aura Minerals Inc. Common Shares (AUGO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LLY achieves a 5.78% return, which is significantly lower than AUGO's 22.99% return.

LLY

• 1D: -2.41%
• 1M: 11.74%
• YTD: 5.78%
• 6M: 10.64%
• 1Y: 40.51%
• 3Y*: 37.45%
• 5Y*: 39.59%
• 10Y*: 33.45%

AUGO

• 1D: 7.62%
• 1M: -22.38%
• YTD: 22.99%
• 6M: 33.09%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LLY vs. AUGO - Yearly Performance Comparison

	2026 (YTD)	2025
LLY Eli Lilly and Company	5.78%	39.76%
AUGO Aura Minerals Inc. Common Shares	22.99%	111.07%

Correlation

The correlation between LLY and AUGO is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jul 16, 2025	0.04

Fundamentals

Market Cap LLY : $1.02T AUGO : $5.04B
EPS LLY : $28.14 AUGO : $1.10
PE Ratio LLY : 40.26 AUGO : 55.27
PS Ratio LLY : 14.08 AUGO : 4.31
PB Ratio LLY : 32.54 AUGO : 16.69
Total Revenue (TTM) LLY : $72.25B AUGO : $1.14B
Gross Profit (TTM) LLY : $59.75B AUGO : $644.49M
EBITDA (TTM) LLY : $32.97B AUGO : $394.37M

Return for Risk

LLY vs. AUGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY

LLY Risk / Return Rank: 73
LLY Sharpe Ratio Rank: 75
LLY Sortino Ratio Rank: 70
LLY Omega Ratio Rank: 71
LLY Calmar Ratio Rank: 74
LLY Martin Ratio Rank: 75

AUGO

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LLY vs. AUGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and Aura Minerals Inc. Common Shares (AUGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LLY	AUGO	Difference
Sharpe ratio: Return per unit of total volatility	1.07	—	—
Sortino ratio: Return per unit of downside risk	1.62	—	—
Omega ratio: Gain probability vs. loss probability	1.22	—	—
Calmar ratio: Return relative to maximum drawdown	1.72	—	—
Martin ratio: Return relative to average drawdown	4.28	—	—

Drawdowns

LLY vs. AUGO - Drawdown Comparison

The maximum LLY drawdown since its inception was -68.24%, which is greater than AUGO's maximum drawdown of -50.65%. Use the drawdown chart below to compare losses from any high point for LLY and AUGO.

Drawdown Indicators

	LLY	AUGO	Difference
Max Drawdown Largest peak-to-trough decline	-68.24%	-50.65%	-17.59%
Max Drawdown (1Y) Largest decline over 1 year	-23.64%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-34.48%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-34.48%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-34.48%	—	—
Current Drawdown Current decline from peak	-2.41%	-43.63%	+41.22%
Average Drawdown Average peak-to-trough decline	-19.21%	-9.38%	-9.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.49%	—	—

Volatility

Volatility by Period

	LLY	AUGO	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.27%	—	—
Volatility (6M) Calculated over the trailing 6-month period	27.16%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	38.01%	67.47%	-29.46%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.46%	67.47%	-35.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.19%	67.47%	-37.28%

Dividends

LLY vs. AUGO - Dividend Comparison

LLY's dividend yield for the trailing twelve months is around 0.57%, less than AUGO's 3.70% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AUGO Aura Minerals Inc. Common Shares	3.70%	1.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LLY Eli Lilly and Company	0.57%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%

Financials

LLY vs. AUGO - Profitability Comparison

The chart below illustrates the profitability comparison between Eli Lilly and Company and Aura Minerals Inc. Common Shares over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

AUGO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. Common Shares reported a gross profit of 193.50M and revenue of 382.61M. Therefore, the gross margin over that period was 50.6%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

AUGO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. Common Shares reported an operating income of 172.35M and revenue of 382.61M, resulting in an operating margin of 45.1%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.

AUGO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. Common Shares reported a net income of 95.16M and revenue of 382.61M, resulting in a net margin of 24.9%.

Frequently Asked Questions

Can I hold both LLY and AUGO in my portfolio?

LLY and AUGO have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.